The UAB NF Program is internationally recognized for its contributions to outstanding clinical care, research, and education related to all forms of neurofibromatosis (NF1, NF2, and schwannomatosis). We are the national coordinating center for the NF Clinical Trials Consortium, funded by the Department of Defense to perform clinical trials for all forms of neurofibromatsis.
UAB-HudsonAlpha Center for Genomic Medicine awards first pilot grantsThe UAB-HudsonAlpha Center for Genomic Medicine has bestowed its first research grants as part of the collaboration between the University of Alabama at Birmingham and HudsonAlpha Institute for Biotechnology. The three pilot grants, each of $100,000 for up to two years, have been given to collaborative teams of one researcher from UAB and one from HudsonAlpha to pursue research projects in cancer and cardiac disease.
Clinical Services: Our goal is to deliver outstanding care for patients and families through integrated clinical and laboratory services. For some conditions, we are considered a national and international referral source.
Research: We seek to expand knowledge and create new applications through laboratory and clinical research along the continuum from fundamental studies to preclinical investigations, to bench-to bedside translation, to clinical practice and community implementation.